A family of'aminoacyl alkyl citrate compounds called viridiofungins, are novel squalene synthase inhibitors. The compounds have broad spectrum fungicidal activity but lack antibacterial activity. Although the compoundsinhibit squalene synthase, the first committed step in ergosterol biosynthesis, results presented in this paper show that inhibition of fungal growth is not related to inhibition of ergosterol synthesis.
The preceding paper described the isolation and structure elucidation of novel amino alkyl citrate compounds called viridiofungins^.
The compounds which inhibit squalene synthase have broad spectrum antifungal activity but lack antibacterial activity. This paper describes the results showing that the antifungal mode of action of these compounds is unrelated to inhibition of ergosterol synthesis despite the fact that viridiofungins inhibit squalene synthase.
Methods

Fermentation
Culture MF 5628 {Trichoderma viride) produced viridiofungin. The compoundwas produced in a two stage fermentation process consisting of growth in seed medium A2) followed by subsequent product fermentation in appropriate fermentation media. Frozen vegetative mycelia (FVM)of the culture were prepared and used to inoculate flasks of seed medium A. Substantial vegetative fungal growth was obtained from seed flasks after 45~48 hours incubation at 25°C on gyratory shaker (220 rpm). Production flasks were inoculated by aseptic transfer of 2 mis of seed growth and were incubated at 25°C in a medium consisting of yellow cornmeal, 50.0g/ liter; yeast extract, l.Og/liter; and sucrose, 80.0g/liter; dispensed 45 ml/nonbaffied 250-ml Erlenmeyer flask. Flasks were agitated at 220rpmon a gyratory shaker.
Production flasks were harvested after 7 days by MEK extraction of the mycelial growth. Content of viridiofungin in the MEKextracts was determined by HPLC analysis and shown to be 450 jug/ml. Antimicrobial Activity Antifungal activity of viridiofungins were determined using microdilution methods with standard U-bottom at 1 x 103 spore/ml were added to inhibitor-containing microtiter dishes. After 20 hours at 29°C, the microtiter dishes were examined to determine the lowest concentration necessary to prevent visible growth, the minimal inhibitory concentration (MIC). Aliquots of 0. 1 ml were diluted and plated to determine the effect of the compound on the viability of the cells. The lowest concentration to reduce the number of viable cells by 95% compared to the inoculum was defined as the minimum fungicidal concentration (MFC). The effect of the compoundon bacteria was assessed using agar diffusion assays3>4 concentration of inhibitor that gave 50%inhibition as determined from these plots.
Effect of Viridiofungin A on Fungal Macromolecular
Synthesis The effect of viridiofungins on macromolecularsynthesis was evaluated using whole cell labeling methods. The MIC of the compounds under the growth conditions used to radiolabel the macromolecules was determined. The organisms were grown to exponential phase in SM supplemented with 1 fiM adenine and leucine and adjusted Fatty acids were recovered by acidifying the remaining alkaline layer and extracting with petroleum ether. The extracts were dried under vacuum, dissolved in chloro- viridiofungin A, B and C did not correlate with the compounds' potency as squalene synthase inhibitors.
Effect of Viridiofungin on
Macromolecular Synthesis In order to determine whether the antifungal activity of the viridiofungins was accounted for by inhibition of squalene synthase with resulting decreases in ergosterol, the effect of an MIClevel of the compoundson cellular ergosterol biosynthesis was assessed in C. albicans MY 1055. Results presented in Table 3 show that the pM squalene synthase inhibitor, zaragozic acid A, reduced the incorporation of labeled acetate into the nonsaponiflable lipid extract by more than 75% without significant effect on the incorporation of label into the fatty acid containing extract. In contrast, the viridiofungins, at the MIC, did not specifically reduce the incorporation of labeled acetate into the nonsaponifiable lipid extract. The most potent squalene synthase inhibitor in the viridiofungin class, viridiofungin C, reduced the incorporation of acetate into NSL and fatty acid containing lipid extracts by more than 90%. The most active antifungal in the series, viridiofungin A, also reduced acetate incorporation into both lipid extracts by 50%. There was Table 4 show that viridiofungin A did not reduce acetate incorporation into the lipid extracts of U. zeae. Since the nonsaponifiable lipid extract did not contain different labeled lipids compared to the control, it was concluded that viridiofungin A did not affect ergosterol synthesis. Results also presented in Table 4 show that concentrations of viridiofungin A more than 20-times higher than the MIC did not reduce the incorporation of labeled adenine or leucine into RNAor protein.
Discussion
Viridiofungins, a novel class of amino alkyl citrate compounds, are broad spectrum, fungicidal antifungal agents which lack antibacterial activity. The compounds do inhibit squalene synthase but are 4 orders of magnitude less active compared to the zaragozic acids.
The antifungal activity of viridiofungin, however, is not accounted for by a reduction in ergosterol synthesis via inhibition of squalene synthase. This conclusion is based on the fact that there is no correlation between the potency of the compounds as inhibitors of squalene synthase and antifungal activity. Additionally, at concentrations sufficient to inhibit the growth of Candida albicans and Ustilago zeae, specific inhibition of ergos- Mandala et al.8) show that the mechanism of action of these novel, fungicidal natural products are due to effects on sphingolipid metabolism. 
